AMCP-NEXUS 2022: Real-world adherence and persistence to single versus multiple inhaler triple therapy
The AMCP-NEXUS 2022 National Meeting took place October 11–14, 2022 in National Harbour, Maryland, United States.
Guidance-based care of uncontrolled asthma despite ICS/LABA requires an individualised approach. In this section you will find information on the practical considerations for step-up therapy in asthma.
Asthma Forward is a registered trademark of the GSK group of companies.
©2023 GSK group of companies. All rights reserved.
SE-GBL-FVU-WCNT-200014 | Date of preparation: October 2023